Dole (DOLE) grows 2025 revenue to $9.2B and launches $100M buyback
Dole plc reported solid fourth quarter and full year 2025 results, with full year revenue of
The Diversified Fresh Produce segments drove growth and offset weaker Fresh Fruit margins caused by higher fruit and shipping costs, including impacts from Tropical Storm Sara. Net debt fell to
The board authorized share repurchases up to
Positive
- None.
Negative
- None.
Insights
Dole delivered modest EBITDA growth, de-levered, and added capital returns.
Dole plc grew 2025 revenue to
Net income declined to
Capital allocation shifted more toward shareholders, with board authorization for up to
(Exact Name of Registrant as Specified in Charter) | ||
(State or other jurisdiction of incorporation) | (Commission File Number) | (I.R.S. Employer Identification No.) | ||||||||||||||||||||||||||||||
Title of each class | Trading Symbol (s) | Name of each exchange on which registered | ||||||
99.1 | Dole plc Press Release issued February 25, 2026 – Dole plc Reports Fourth Quarter and Full Year 2025 Financial Results | |||||||||||||
104 | Cover Page Interactive Data File (embedded within the Inline XBRL document). | |||||||||||||
Date: | February 25, 2026 | DOLE PLC | |||||||||
(Registrant) | |||||||||||
By: /s/ Jacinta Devine | |||||||||||
Name: Jacinta Devine | |||||||||||
Title: Chief Financial Officer | |||||||||||
Three Months Ended | Year Ended | ||||||||||||||||||||||
December 31, 2025 | December 31, 2024 | December 31, 2025 | December 31, 2024 | ||||||||||||||||||||
(U.S. Dollars in millions, except per share amounts) (Unaudited) | |||||||||||||||||||||||
Revenue | 2,366 | 2,167 | 9,173 | 8,475 | |||||||||||||||||||
Income from Continuing Operations2 | 6.8 | 29.6 | 127.9 | 172.3 | |||||||||||||||||||
Net Income (Loss) | 6.0 | (31.6) | 82.0 | 143.4 | |||||||||||||||||||
Net (Loss) Income attributable to Dole plc | (2.7) | (39.1) | 51.3 | 125.5 | |||||||||||||||||||
Diluted EPS from Continuing Operations | (0.02) | 0.23 | 1.01 | 1.62 | |||||||||||||||||||
Diluted EPS | (0.03) | (0.41) | 0.53 | 1.32 | |||||||||||||||||||
Adjusted EBITDA1 | 72.7 | 74.6 | 395.4 | 392.2 | |||||||||||||||||||
Adjusted Net Income1 | 13.8 | 15.3 | 115.0 | 120.9 | |||||||||||||||||||
Adjusted Diluted EPS1 | 0.14 | 0.16 | 1.20 | 1.27 | |||||||||||||||||||
Three Months Ended | |||||||||||||||||||||||
December 31, 2025 | December 31, 2024 | ||||||||||||||||||||||
(U.S. Dollars in thousands) (unaudited) | |||||||||||||||||||||||
Revenue | Adjusted EBITDA1 | Revenue | Adjusted EBITDA1 | ||||||||||||||||||||
Fresh Fruit | $ | 874,036 | $ | 26,602 | $ | 819,066 | $ | 31,890 | |||||||||||||||
Diversified Fresh Produce - EMEA | 1,025,887 | 32,597 | 910,604 | 32,487 | |||||||||||||||||||
Diversified Fresh Produce - Americas & ROW | 486,455 | 13,468 | 463,285 | 10,234 | |||||||||||||||||||
Intersegment | (20,216) | — | (25,491) | — | |||||||||||||||||||
Total | $ | 2,366,162 | $ | 72,667 | $ | 2,167,464 | $ | 74,611 | |||||||||||||||
Year Ended | |||||||||||||||||||||||
December 31, 2025 | December 31, 2024 | ||||||||||||||||||||||
(U.S. Dollars in thousands) (unaudited) | |||||||||||||||||||||||
Revenue | Adjusted EBITDA1 | Revenue | Adjusted EBITDA1 | ||||||||||||||||||||
Fresh Fruit | $ | 3,615,127 | $ | 189,842 | $ | 3,293,527 | $ | 214,848 | |||||||||||||||
Diversified Fresh Produce - EMEA | 4,016,573 | 149,981 | 3,608,692 | 131,504 | |||||||||||||||||||
Diversified Fresh Produce - Americas & ROW | 1,656,207 | 55,553 | 1,686,281 | 45,851 | |||||||||||||||||||
Intersegment | (115,000) | — | (113,157) | — | |||||||||||||||||||
Total | $ | 9,172,907 | $ | 395,376 | $ | 8,475,343 | $ | 392,203 | |||||||||||||||
Three Months Ended | Year Ended | ||||||||||||||||||||||
December 31, 2025 | December 31, 2024 | December 31, 2025 | December 31, 2024 | ||||||||||||||||||||
(U.S. Dollars and shares in thousands, except per share amounts) | |||||||||||||||||||||||
Revenue, net | $ | 2,366,161 | $ | 2,167,464 | $ | 9,172,907 | $ | 8,475,343 | |||||||||||||||
Cost of sales | (2,207,527) | (2,009,045) | (8,458,599) | (7,757,622) | |||||||||||||||||||
Gross profit | 158,634 | 158,419 | 714,308 | 717,721 | |||||||||||||||||||
Selling, marketing, general and administrative expenses | (129,135) | (122,675) | (495,476) | (474,058) | |||||||||||||||||||
Gain on disposal of businesses | 54 | 472 | 606 | 76,417 | |||||||||||||||||||
Gain on asset sales | 1,079 | 747 | 15,045 | 2,648 | |||||||||||||||||||
Impairment of goodwill | — | — | — | (36,684) | |||||||||||||||||||
Impairment and asset write-downs of property, plant and equipment and lease assets | (2,942) | (2,154) | (11,518) | (5,480) | |||||||||||||||||||
Operating income | 27,690 | 34,809 | 222,965 | 280,564 | |||||||||||||||||||
Other income (expense), net | 4,876 | 11,137 | (1,574) | 20,595 | |||||||||||||||||||
Interest income | 3,900 | 2,410 | 13,373 | 10,745 | |||||||||||||||||||
Interest expense | (15,202) | (18,055) | (66,541) | (72,264) | |||||||||||||||||||
Income from continuing operations before income taxes and equity earnings | 21,264 | 30,301 | 168,223 | 239,640 | |||||||||||||||||||
Income tax expense | (21,821) | (264) | (71,003) | (75,649) | |||||||||||||||||||
Equity method earnings (loss) | 7,362 | (403) | 30,714 | 8,308 | |||||||||||||||||||
Income from continuing operations | 6,805 | 29,634 | 127,934 | 172,299 | |||||||||||||||||||
Loss from discontinued operations, net of income taxes | (803) | (61,231) | (45,959) | (28,880) | |||||||||||||||||||
Net income (loss) | 6,002 | (31,597) | 81,975 | 143,419 | |||||||||||||||||||
Less: Net income attributable to noncontrolling interests | (8,666) | (7,552) | (30,656) | (17,906) | |||||||||||||||||||
Net (loss) income attributable to Dole plc | $ | (2,664) | $ | (39,149) | $ | 51,319 | $ | 125,513 | |||||||||||||||
Income (loss) per share - basic: | |||||||||||||||||||||||
Continuing operations | $ | (0.02) | $ | 0.23 | $ | 1.02 | $ | 1.63 | |||||||||||||||
Discontinued operations | (0.01) | (0.64) | (0.48) | (0.31) | |||||||||||||||||||
Net (loss) income per share attributable to Dole plc - basic | $ | (0.03) | $ | (0.41) | $ | 0.54 | $ | 1.32 | |||||||||||||||
Income (loss) per share - diluted: | |||||||||||||||||||||||
Continuing operations | $ | (0.02) | $ | 0.23 | $ | 1.01 | $ | 1.62 | |||||||||||||||
Discontinued operations | (0.01) | (0.64) | (0.48) | (0.30) | |||||||||||||||||||
Net (loss) income per share attributable to Dole plc - diluted | $ | (0.03) | $ | (0.41) | $ | 0.53 | $ | 1.32 | |||||||||||||||
Weighted-average shares: | |||||||||||||||||||||||
Basic | 95,163 | 95,019 | 95,145 | 94,967 | |||||||||||||||||||
Diluted | 96,104 | 95,702 | 95,902 | 95,471 | |||||||||||||||||||
December 31, 2025 | December 31, 2024 | ||||||||||
ASSETS | (U.S. Dollars and shares in thousands) | ||||||||||
Cash and cash equivalents | $ | 267,854 | $ | 330,017 | |||||||
Short-term investments | 6,418 | 6,019 | |||||||||
Trade receivables, net of allowances for credit losses of $20,558 and $19,493, respectively | 539,840 | 473,511 | |||||||||
Grower advance receivables, net of allowances of $37,915 and $29,304, respectively | 143,426 | 104,956 | |||||||||
Other receivables, net of allowances of $17,027 and $15,248, respectively | 121,355 | 125,951 | |||||||||
Inventories, net of allowances of $3,659 and $4,178, respectively | 509,260 | 430,168 | |||||||||
Prepaid expenses | 70,007 | 68,918 | |||||||||
Other current assets | 17,891 | 15,111 | |||||||||
Fresh Vegetables current assets held for sale | — | 281,990 | |||||||||
Assets held for sale | 75,689 | 1,419 | |||||||||
Total current assets | 1,751,740 | 1,838,060 | |||||||||
Long-term investments | 13,827 | 14,630 | |||||||||
Investments in unconsolidated affiliates | 142,082 | 129,322 | |||||||||
Actively marketed property | 53,231 | 45,778 | |||||||||
Property, plant and equipment, net of accumulated depreciation of $619,706 and $502,062, respectively | 1,081,656 | 1,120,366 | |||||||||
Operating lease right-of-use assets | 371,366 | 341,722 | |||||||||
Goodwill | 434,345 | 429,590 | |||||||||
DOLE® brand | 306,280 | 306,280 | |||||||||
Other intangible assets, net of accumulated amortization of $133,022 and $118,956, respectively | 18,997 | 25,238 | |||||||||
Other assets | 133,931 | 112,893 | |||||||||
Deferred tax assets, net | 88,669 | 82,484 | |||||||||
Total assets | $ | 4,396,124 | $ | 4,446,363 | |||||||
LIABILITIES AND EQUITY | |||||||||||
Accounts payable | $ | 712,483 | $ | 648,591 | |||||||
Income taxes payable | 21,805 | 42,753 | |||||||||
Accrued liabilities | 517,989 | 443,145 | |||||||||
Bank overdrafts | 9,611 | 11,443 | |||||||||
Current portion of long-term debt, net | 57,668 | 80,097 | |||||||||
Current maturities of operating leases | 71,379 | 64,357 | |||||||||
Payroll and other tax | 36,320 | 28,056 | |||||||||
Contingent consideration | 3,252 | 3,399 | |||||||||
Pension and postretirement benefits | 18,699 | 18,491 | |||||||||
Fresh Vegetables current liabilities held for sale | — | 214,387 | |||||||||
Liabilities held for sale | 14,047 | — | |||||||||
Dividends payable and other current liabilities | 31,228 | 14,696 | |||||||||
Total current liabilities | 1,494,481 | 1,569,415 | |||||||||
Long-term debt, net | 799,814 | 866,075 | |||||||||
Operating leases, less current maturities | 306,566 | 280,896 | |||||||||
Deferred tax liabilities, net | 90,100 | 84,712 | |||||||||
Income taxes payable, less current portion | — | 6,210 | |||||||||
Contingent consideration, less current portion | 500 | 4,007 | |||||||||
Pension and postretirement benefits, less current portion | 135,900 | 129,870 | |||||||||
Other long-term liabilities | 66,990 | 70,260 | |||||||||
Total liabilities | $ | 2,894,351 | $ | 3,011,445 | |||||||
Redeemable noncontrolling interests | 29,716 | 35,554 | |||||||||
Stockholders’ equity: | |||||||||||
Common stock — $0.01 par value; 300,000 shares authorized and 95,163 and 95,041 shares outstanding as of December 31, 2025 and December 31, 2024, respectively | 952 | 950 | |||||||||
Additional paid-in capital | 804,247 | 801,099 | |||||||||
Retained earnings | 676,371 | 657,430 | |||||||||
Accumulated other comprehensive loss | (117,467) | (166,180) | |||||||||
Total equity attributable to Dole plc | 1,364,103 | 1,293,299 | |||||||||
Equity attributable to noncontrolling interests | 107,954 | 106,065 | |||||||||
Total equity | 1,472,057 | 1,399,364 | |||||||||
Total liabilities, redeemable noncontrolling interests and equity | $ | 4,396,124 | $ | 4,446,363 | |||||||
Year Ended | |||||||||||
December 31, 2025 | December 31, 2024 | ||||||||||
Operating Activities | (U.S. Dollars in thousands) | ||||||||||
Net income | $ | 81,975 | $ | 143,419 | |||||||
Loss from discontinued operations, net of income taxes | 45,959 | 28,880 | |||||||||
Income from continuing operations | 127,934 | 172,299 | |||||||||
Adjustments to reconcile income from continuing operations to net cash provided by (used in) operating activities - continuing operations: | |||||||||||
Depreciation and amortization | 112,661 | 98,818 | |||||||||
Impairment of goodwill | — | 36,684 | |||||||||
Impairment and asset write-downs of property, plant and equipment and lease assets | 11,518 | 5,480 | |||||||||
Net gain on sale of assets | (15,045) | (2,648) | |||||||||
Net gain on sale of businesses | (606) | (76,417) | |||||||||
Net loss (gain) on financial instruments | 20,308 | (12,397) | |||||||||
Stock-based compensation expense | 6,854 | 7,951 | |||||||||
Equity method earnings | (30,714) | (8,308) | |||||||||
Amortization of debt discounts and debt issuance costs | 4,127 | 7,746 | |||||||||
Deferred tax expense (benefit) | 12,975 | (17,588) | |||||||||
Pension and other postretirement benefit plan expense | 7,485 | 5,404 | |||||||||
Dividends received from equity method investees | 12,688 | 7,049 | |||||||||
Gain on insurance proceeds | (17,447) | — | |||||||||
Other | 363 | (247) | |||||||||
Changes in operating assets and liabilities: | |||||||||||
Receivables, net of allowances | (124,817) | (20,603) | |||||||||
Inventories | (67,998) | (70,810) | |||||||||
Prepaids, other current assets and other assets | 2,692 | (281) | |||||||||
Accounts payable, accrued liabilities and other liabilities | 60,228 | 130,589 | |||||||||
Net cash provided by operating activities - continuing operations | 123,206 | 262,721 | |||||||||
Investing Activities | |||||||||||
Sales of assets | 13,645 | 5,011 | |||||||||
Capital expenditures | (121,497) | (82,435) | |||||||||
Proceeds from sale of businesses, net of transaction costs and cash transferred | 68,621 | 117,935 | |||||||||
Insurance proceeds | 19,606 | 527 | |||||||||
Sales (purchases) of unconsolidated affiliates | 3,152 | (1,769) | |||||||||
Acquisitions, net of cash acquired | (2,248) | (926) | |||||||||
Other | (276) | (2,563) | |||||||||
Net cash (used in) provided by investing activities - continuing operations | (18,997) | 35,780 | |||||||||
Financing Activities | |||||||||||
Proceeds from borrowings and overdrafts | 1,838,112 | 1,517,106 | |||||||||
Repayments on borrowings and overdrafts and payment of debt refinancing fees | (1,926,927) | (1,696,130) | |||||||||
Dividends paid to shareholders | (31,568) | (30,551) | |||||||||
Dividends paid to noncontrolling interests and other noncontrolling interest activity, net | (28,076) | (26,703) | |||||||||
Payments of contingent consideration | (2,801) | (1,567) | |||||||||
Net cash used in financing activities - continuing operations | (151,260) | (237,845) | |||||||||
Effect of foreign currency exchange rate changes on cash | 17,724 | (15,241) | |||||||||
Net cash (used in) provided by operating activities - discontinued operations | (27,912) | 22,592 | |||||||||
Net cash used in investing activities - discontinued operations | (6,626) | (13,293) | |||||||||
Cash (used in) provided by discontinued operations, net | (34,538) | 9,299 | |||||||||
(Decrease) increase in cash and cash equivalents | (63,865) | 54,714 | |||||||||
Cash and cash equivalents at beginning of period, including discontinued operations | 331,719 | 277,005 | |||||||||
Cash and cash equivalents at end of period, including discontinued operations | $ | 267,854 | $ | 331,719 | |||||||
Supplemental cash flow information: | |||||||||||
Income tax payments, including discontinued operations, net of refunds | $ | (100,100) | $ | (77,967) | |||||||
Interest payments on borrowings | $ | (63,685) | $ | (67,397) | |||||||
Non-cash Investing and Financing Activities: | |||||||||||
Accrued property, plant and equipment | $ | (2,724) | $ | (2,983) | |||||||
Three Months Ended | Year Ended | ||||||||||||||||||||||
December 31, 2025 | December 31, 2024 | December 31, 2025 | December 31, 2024 | ||||||||||||||||||||
(U.S. Dollars in thousands) | |||||||||||||||||||||||
Net income (loss) (Reported GAAP) | $ | 6,002 | $ | (31,597) | $ | 81,975 | $ | 143,419 | |||||||||||||||
Loss from discontinued operations, net of income taxes | 803 | 61,231 | 45,959 | 28,880 | |||||||||||||||||||
Income from continuing operations (Reported GAAP) | 6,805 | 29,634 | 127,934 | 172,299 | |||||||||||||||||||
Income tax expense | 21,821 | 264 | 71,003 | 75,649 | |||||||||||||||||||
Interest expense | 15,202 | 18,055 | 66,541 | 72,264 | |||||||||||||||||||
Mark to market (gains) losses | (3,316) | (11,356) | 18,753 | (10,139) | |||||||||||||||||||
Gain on asset sales | (1,076) | (90) | (12,254) | (125) | |||||||||||||||||||
Gain on disposal of businesses | (54) | (472) | (606) | (76,417) | |||||||||||||||||||
Insurance proceeds, net of asset write-downs | (4,938) | (187) | (16,812) | (2,878) | |||||||||||||||||||
Impairment of property, plant and equipment and lease assets | 2,403 | 740 | 10,611 | 740 | |||||||||||||||||||
Impairment of goodwill | — | — | — | 36,684 | |||||||||||||||||||
Restructuring and costs for legal matters | 3,203 | 459 | 3,786 | 459 | |||||||||||||||||||
Debt refinancing expenses | — | — | 3,182 | — | |||||||||||||||||||
Other items1,2 | 801 | 11 | 1,115 | (7) | |||||||||||||||||||
Adjustments from equity method investments | 239 | 9,294 | 867 | 16,258 | |||||||||||||||||||
Adjusted EBIT (Non-GAAP) | 41,090 | 46,352 | 274,120 | 284,787 | |||||||||||||||||||
Depreciation | 27,228 | 24,410 | 105,559 | 91,262 | |||||||||||||||||||
Amortization of intangible assets | 1,788 | 1,776 | 7,102 | 7,556 | |||||||||||||||||||
Depreciation and amortization adjustments from equity method investments | 2,561 | 2,073 | 8,595 | 8,598 | |||||||||||||||||||
Adjusted EBITDA (Non-GAAP) | $ | 72,667 | $ | 74,611 | $ | 395,376 | $ | 392,203 | |||||||||||||||
Three Months Ended | Year Ended | ||||||||||||||||||||||
December 31, 2025 | December 31, 2024 | December 31, 2025 | December 31, 2024 | ||||||||||||||||||||
(U.S. Dollars and shares in thousands, except per share amounts) | |||||||||||||||||||||||
Net (loss) income attributable to Dole plc (Reported GAAP) | $ | (2,664) | $ | (39,149) | $ | 51,319 | $ | 125,513 | |||||||||||||||
Loss from discontinued operations, net of income taxes | 803 | 61,231 | 45,959 | 28,880 | |||||||||||||||||||
Income from continuing operations attributable to Dole plc | (1,861) | 22,082 | 97,278 | 154,393 | |||||||||||||||||||
Amortization of intangible assets | 1,788 | 1,776 | 7,102 | 7,556 | |||||||||||||||||||
Mark to market (gains) losses | (3,316) | (11,356) | 18,753 | (10,139) | |||||||||||||||||||
Gain on asset sales | (1,076) | (90) | (12,254) | (125) | |||||||||||||||||||
Gain on disposal of businesses | (54) | (472) | (606) | (76,417) | |||||||||||||||||||
Insurance proceeds, net of asset write-downs | (4,938) | (187) | (16,812) | (2,878) | |||||||||||||||||||
Impairment of property, plant and equipment and lease assets | 2,403 | 740 | 10,611 | 740 | |||||||||||||||||||
Impairment of goodwill | — | — | — | 36,684 | |||||||||||||||||||
Restructuring and costs for legal matters | 3,203 | 459 | 3,786 | 459 | |||||||||||||||||||
Debt refinancing expenses | — | — | 3,182 | — | |||||||||||||||||||
Other items3,4 | 2,279 | 11 | 2,593 | (7) | |||||||||||||||||||
Adjustments from equity method investments | (2,955) | 7,926 | (10,115) | 9,708 | |||||||||||||||||||
Income tax on items above and discrete tax items | 17,338 | (5,338) | 12,846 | 13,162 | |||||||||||||||||||
NCI impact on items above | 978 | (271) | (1,324) | (12,239) | |||||||||||||||||||
Adjusted Net Income for Adjusted EPS calculation (Non-GAAP) | $ | 13,789 | $ | 15,280 | $ | 115,040 | $ | 120,897 | |||||||||||||||
Adjusted earnings per share – basic (Non-GAAP) | $ | 0.14 | $ | 0.16 | $ | 1.21 | $ | 1.27 | |||||||||||||||
Adjusted earnings per share – diluted (Non-GAAP) | $ | 0.14 | $ | 0.16 | $ | 1.20 | $ | 1.27 | |||||||||||||||
Weighted average shares outstanding – basic | 95,163 | 95,019 | 95,145 | 94,967 | |||||||||||||||||||
Weighted average shares outstanding – diluted | 96,104 | 95,702 | 95,902 | 95,471 | |||||||||||||||||||
Three Months Ended December 31, 2025 (U.S. Dollars in thousands) | |||||||||||||||||||||||
Revenue, net | Cost of sales | Gross profit | Gross Margin % | Selling, marketing, general and administration expenses | Other operating items5 | Operating Income | |||||||||||||||||
Reported (GAAP) | $ | 2,366,161 | (2,207,527) | 158,634 | 6.7 | % | (129,135) | (1,809) | $ | 27,690 | |||||||||||||
Loss from discontinued operations, net of income taxes | — | — | — | — | — | — | |||||||||||||||||
Amortization of intangible assets | — | — | — | 1,788 | — | 1,788 | |||||||||||||||||
Mark to market (gains) losses | — | (2,393) | (2,393) | — | — | (2,393) | |||||||||||||||||
Gain on asset sales | — | — | — | — | (1,076) | (1,076) | |||||||||||||||||
Gain on disposal of businesses | — | — | — | — | (54) | (54) | |||||||||||||||||
Insurance proceeds, net of asset write-downs | — | 544 | 544 | — | — | 544 | |||||||||||||||||
Impairment of property, plant and equipment and lease assets | — | — | — | — | 2,403 | 2,403 | |||||||||||||||||
Restructuring and costs for legal matters | — | — | — | 3,204 | — | 3,204 | |||||||||||||||||
Debt refinancing expenses | — | — | — | — | — | — | |||||||||||||||||
Other items | — | 54 | 54 | — | — | 54 | |||||||||||||||||
Adjustments from equity method investments | — | — | — | — | — | — | |||||||||||||||||
Income tax on items above and discrete tax items | — | — | — | — | — | — | |||||||||||||||||
NCI impact on items above | — | — | — | — | — | — | |||||||||||||||||
Adjusted (Non-GAAP) | $ | 2,366,161 | (2,209,322) | 156,839 | 6.6 | % | (124,143) | (536) | $ | 32,160 | |||||||||||||
Three Months Ended December 31, 2024 (U.S. Dollars in thousands) | |||||||||||||||||||||||
Revenue, net | Cost of sales | Gross profit | Gross Margin % | Selling, marketing, general and administration expenses | Other operating items6 | Operating Income | |||||||||||||||||
Reported (GAAP) | $ | 2,167,464 | (2,009,045) | 158,419 | 7.3 | % | (122,675) | (935) | $ | 34,809 | |||||||||||||
Loss from discontinued operations, net of income taxes | — | — | — | — | — | — | |||||||||||||||||
Amortization of intangible assets | — | — | — | 1,776 | — | 1,776 | |||||||||||||||||
Mark to market (gains) losses | — | (378) | (378) | — | — | (378) | |||||||||||||||||
Gain on asset sales | — | — | — | — | (90) | (90) | |||||||||||||||||
Gain on disposal of businesses | — | — | — | — | (472) | (472) | |||||||||||||||||
Insurance proceeds, net of asset write-downs | — | (187) | (187) | — | — | (187) | |||||||||||||||||
Impairment of property, plant and equipment and lease assets | — | — | — | — | 740 | 740 | |||||||||||||||||
Restructuring and costs for legal matters | — | — | — | 459 | — | 459 | |||||||||||||||||
Other items | — | 11 | 11 | — | — | 11 | |||||||||||||||||
Adjustments from equity method investments | — | — | — | — | — | — | |||||||||||||||||
Income tax on items above and discrete tax items | — | — | — | — | — | — | |||||||||||||||||
NCI impact on items above | — | — | — | — | — | — | |||||||||||||||||
Adjusted (Non-GAAP) | $ | 2,167,464 | (2,009,599) | 157,865 | 7.3 | % | (120,440) | (757) | $ | 36,668 | |||||||||||||
Three Months Ended December 31, 2025 (U.S. Dollars in thousands) | |||||||||||||||||||||||
Other income (expense), net | Interest income | Interest expense | Income tax expense | Equity earnings | Income from continuing operations | Loss from discontinued operations, net of income taxes | |||||||||||||||||
Reported (GAAP) | $ | 4,876 | 3,900 | (15,202) | (21,821) | 7,362 | 6,805 | $ | (803) | ||||||||||||||
Loss from discontinued operations, net of income taxes | — | — | — | — | — | — | 803 | ||||||||||||||||
Amortization of intangible assets | — | — | — | — | — | 1,788 | — | ||||||||||||||||
Mark to market (gains) losses | (923) | — | — | — | — | (3,316) | — | ||||||||||||||||
Gain on asset sales | — | — | — | — | — | (1,076) | — | ||||||||||||||||
Gain on disposal of businesses | — | — | — | — | — | (54) | — | ||||||||||||||||
Insurance proceeds, net of asset write-downs | (5,482) | — | — | — | — | (4,938) | — | ||||||||||||||||
Impairment of property, plant and equipment and lease assets | — | — | — | — | — | 2,403 | — | ||||||||||||||||
Restructuring and costs for legal matters | — | — | — | — | — | 3,204 | — | ||||||||||||||||
Debt refinancing expenses | — | — | — | — | — | — | — | ||||||||||||||||
Other items | 2,224 | — | — | — | — | 2,278 | — | ||||||||||||||||
Adjustments from equity method investments | — | — | — | — | (2,955) | (2,955) | — | ||||||||||||||||
Income tax on items above and discrete tax items | — | — | — | 17,386 | (48) | 17,338 | — | ||||||||||||||||
NCI impact on items above | — | — | — | — | — | — | — | ||||||||||||||||
Adjusted (Non-GAAP) | $ | 695 | 3,900 | (15,202) | (4,435) | 4,359 | 21,477 | $ | — | ||||||||||||||
Three Months Ended December 31, 2024 (U.S. Dollars in thousands) | |||||||||||||||||||||||
Other income (expense), net | Interest income | Interest expense | Income tax expense | Equity earnings | Income from continuing operations | Loss from discontinued operations, net of income taxes | |||||||||||||||||
Reported (GAAP) | $ | 11,137 | 2,410 | (18,055) | (264) | (403) | 29,634 | $ | (61,231) | ||||||||||||||
Loss (income) from discontinued operations, net of income taxes | — | — | — | — | — | — | 61,231 | ||||||||||||||||
Amortization of intangible assets | — | — | — | — | — | 1,776 | — | ||||||||||||||||
Mark to market losses | (10,978) | — | — | — | — | (11,356) | — | ||||||||||||||||
Gain on asset sales | — | — | — | — | — | (90) | — | ||||||||||||||||
Gain on disposal of businesses | — | — | — | — | — | (472) | — | ||||||||||||||||
Insurance proceeds, net of asset write-downs | — | — | — | — | — | (187) | — | ||||||||||||||||
Impairment of property, plant and equipment and lease assets | — | — | — | — | — | 740 | — | ||||||||||||||||
Restructuring and costs for legal matters | — | — | — | — | — | 459 | — | ||||||||||||||||
Other items | — | — | — | — | — | 11 | — | ||||||||||||||||
Adjustments from equity method investments | — | — | — | — | 7,926 | 7,926 | — | ||||||||||||||||
Income tax on items above and discrete tax items | — | — | — | (5,240) | (98) | (5,338) | — | ||||||||||||||||
NCI impact on items above | — | — | — | — | — | — | — | ||||||||||||||||
Adjusted (Non-GAAP) | $ | 159 | 2,410 | (18,055) | (5,504) | 7,425 | 23,103 | $ | — | ||||||||||||||
Three Months Ended December 31, 2025 (U.S. Dollars and shares in thousands, except per share amounts) | ||||||||||||||
Net income (loss) | Net income attributable to noncontrolling interests | Net (loss) income attributable to Dole plc | Diluted net income per share | |||||||||||
Reported (GAAP) | $ | 6,002 | (8,666) | $ | (2,664) | $ | (0.03) | |||||||
Loss from discontinued operations, net of income taxes | 803 | — | 803 | |||||||||||
Amortization of intangible assets | 1,788 | — | 1,788 | |||||||||||
Mark to market (gains) losses | (3,316) | — | (3,316) | |||||||||||
Gain on asset sales | (1,076) | — | (1,076) | |||||||||||
Gain on disposal of businesses | (54) | — | (54) | |||||||||||
Insurance proceeds, net of asset write-downs | (4,938) | — | (4,938) | |||||||||||
Impairment of property, plant and equipment and lease assets | 2,403 | — | 2,403 | |||||||||||
Restructuring and costs for legal matters | 3,204 | — | 3,204 | |||||||||||
Debt refinancing expenses | — | — | — | |||||||||||
Other items | 2,278 | — | 2,278 | |||||||||||
Adjustments from equity method investments | (2,955) | — | (2,955) | |||||||||||
Income tax on items above and discrete tax items | 17,338 | — | 17,338 | |||||||||||
NCI impact on items above | — | 978 | 978 | |||||||||||
Adjusted (Non-GAAP) | $ | 21,477 | (7,688) | $ | 13,789 | $ | 0.14 | |||||||
Weighted average shares outstanding – diluted | 96,104 | |||||||||||||
Three Months Ended December 31, 2024 (U.S. Dollars and shares in thousands, except per share amounts) | ||||||||||||||
Net income (loss) | Net income attributable to noncontrolling interests | Net (loss) income attributable to Dole plc | Diluted net income per share | |||||||||||
Reported (GAAP) | $ | (31,597) | (7,552) | $ | (39,149) | $ | (0.41) | |||||||
Loss from discontinued operations, net of income taxes | 61,231 | — | 61,231 | |||||||||||
Amortization of intangible assets | 1,776 | — | 1,776 | |||||||||||
Mark to market (gains) losses | (11,356) | — | (11,356) | |||||||||||
Gain on asset sales | (90) | — | (90) | |||||||||||
Gain on disposal of businesses | (472) | — | (472) | |||||||||||
Insurance proceeds, net of asset write-downs | (187) | — | (187) | |||||||||||
Impairment of property, plant and equipment and lease assets | 740 | — | 740 | |||||||||||
Restructuring and costs for legal matters | 459 | — | 459 | |||||||||||
Other items | 11 | — | 11 | |||||||||||
Adjustments from equity method investments | 7,926 | — | 7,926 | |||||||||||
Income tax on items above and discrete tax items | (5,338) | — | (5,338) | |||||||||||
NCI impact on items above | — | (271) | (271) | |||||||||||
Adjusted (Non-GAAP) | $ | 23,103 | (7,823) | $ | 15,280 | $ | 0.16 | |||||||
Weighted average shares outstanding – diluted | 95,702 | |||||||||||||
Year Ended December 31, 2025 (U.S. Dollars in thousands) | |||||||||||||||||||||||
Revenue, net | Cost of sales | Gross profit | Gross Margin % | Selling, marketing, general and administration expenses | Other operating items7 | Operating Income | |||||||||||||||||
Reported (GAAP) | $ | 9,172,907 | (8,458,599) | 714,308 | 7.8 | % | (495,476) | 4,133 | $ | 222,965 | |||||||||||||
Loss from discontinued operations, net of income taxes | — | — | — | — | — | — | |||||||||||||||||
Amortization of intangible assets | — | — | — | 7,102 | — | 7,102 | |||||||||||||||||
Mark to market (gains) losses | — | (517) | (517) | — | — | (517) | |||||||||||||||||
Gain on asset sales | — | — | — | — | (12,254) | (12,254) | |||||||||||||||||
Gain on disposal of businesses | — | — | — | — | (606) | (606) | |||||||||||||||||
Insurance proceeds, net of asset write-downs | — | (1,342) | (1,342) | — | — | (1,342) | |||||||||||||||||
Impairment of property, plant and equipment and lease assets | — | — | — | — | 10,611 | 10,611 | |||||||||||||||||
Restructuring and costs for legal matters | — | — | — | 3,786 | — | 3,786 | |||||||||||||||||
Debt refinancing expenses | — | — | — | — | — | — | |||||||||||||||||
Other items | — | 226 | 226 | 130 | — | 356 | |||||||||||||||||
Adjustments from equity method investments | — | — | — | — | — | — | |||||||||||||||||
Income tax on items above and discrete tax items | — | — | — | — | — | — | |||||||||||||||||
NCI impact on items above | — | — | — | — | — | — | |||||||||||||||||
Adjusted (Non-GAAP) | $ | 9,172,907 | (8,460,232) | 712,675 | 7.8 | % | (484,458) | 1,884 | $ | 230,101 | |||||||||||||
Year Ended December 31, 2024 (U.S. Dollars in thousands) | |||||||||||||||||||||||
Revenue, net | Cost of sales | Gross profit | Gross Margin % | Selling, marketing, general and administration expenses | Other operating items8 | Operating Income | |||||||||||||||||
Reported (GAAP) | $ | 8,475,343 | (7,757,622) | 717,721 | 8.5 | % | (474,058) | 36,901 | $ | 280,564 | |||||||||||||
Loss from discontinued operations, net of income taxes | — | — | — | — | — | — | |||||||||||||||||
Amortization of intangible assets | — | — | — | 7,556 | — | 7,556 | |||||||||||||||||
Mark to market (gains) losses | — | (228) | (228) | — | — | (228) | |||||||||||||||||
Gain on asset sales | — | — | — | — | (125) | (125) | |||||||||||||||||
Gain on disposal of businesses | — | — | — | — | (76,417) | (76,417) | |||||||||||||||||
Insurance proceeds, net of asset write-downs | — | (2,878) | (2,878) | — | — | (2,878) | |||||||||||||||||
Impairment of property, plant and equipment and lease assets | — | — | — | — | 740 | 740 | |||||||||||||||||
Impairment of goodwill | — | — | — | — | 36,684 | 36,684 | |||||||||||||||||
Restructuring and costs for legal matters | — | — | — | 459 | — | 459 | |||||||||||||||||
Other items | — | 73 | 73 | — | — | 73 | |||||||||||||||||
Adjustments from equity method investments | — | — | — | — | — | — | |||||||||||||||||
Income tax on items above and discrete tax items | — | — | — | — | — | — | |||||||||||||||||
NCI impact on items above | — | — | — | — | — | — | |||||||||||||||||
Adjusted (Non-GAAP) | $ | 8,475,343 | (7,760,655) | 714,688 | 8.4 | % | (466,043) | (2,217) | $ | 246,428 | |||||||||||||
Year Ended December 31, 2025 (U.S. Dollars in thousands) | |||||||||||||||||||||||
Other income (expense), net | Interest income | Interest expense | Income tax expense | Equity earnings | Income from continuing operations | Loss from discontinued operations, net of income taxes | |||||||||||||||||
Reported (GAAP) | $ | (1,574) | 13,373 | (66,541) | (71,003) | 30,714 | 127,934 | $ | (45,959) | ||||||||||||||
Loss from discontinued operations, net of income taxes | — | — | — | — | — | — | 45,959 | ||||||||||||||||
Amortization of intangible assets | — | — | — | — | — | 7,102 | — | ||||||||||||||||
Mark to market (gains) losses | 19,270 | — | — | — | — | 18,753 | — | ||||||||||||||||
Gain on asset sales | — | — | — | — | — | (12,254) | — | ||||||||||||||||
Gain on disposal of businesses | — | — | — | — | — | (606) | — | ||||||||||||||||
Insurance proceeds, net of asset write-downs | (15,470) | — | — | — | — | (16,812) | — | ||||||||||||||||
Impairment of property, plant and equipment and lease assets | — | — | — | — | — | 10,611 | — | ||||||||||||||||
Restructuring and costs for legal matters | — | — | — | — | — | 3,786 | — | ||||||||||||||||
Debt refinancing expenses | 3,182 | — | — | — | — | 3,182 | — | ||||||||||||||||
Other items | 2,237 | — | — | — | — | 2,593 | — | ||||||||||||||||
Adjustments from equity method investments | — | — | — | — | (10,115) | (10,115) | — | ||||||||||||||||
Income tax on items above and discrete tax items | — | — | — | 12,258 | 588 | 12,846 | — | ||||||||||||||||
NCI impact on items above | — | — | — | — | — | — | — | ||||||||||||||||
Adjusted (Non-GAAP) | $ | 7,645 | 13,373 | (66,541) | (58,745) | 21,187 | 147,020 | $ | — | ||||||||||||||
Year Ended December 31, 2024 (U.S. Dollars in thousands) | |||||||||||||||||||||||
Other income (expense), net | Interest income | Interest expense | Income tax expense | Equity earnings | Income from continuing operations | Loss from discontinued operations, net of income taxes | |||||||||||||||||
Reported (GAAP) | $ | 20,595 | 10,745 | (72,264) | (75,649) | 8,308 | 172,299 | $ | (28,880) | ||||||||||||||
Loss from discontinued operations, net of income taxes | — | — | — | — | — | — | 28,880 | ||||||||||||||||
Amortization of intangible assets | — | — | — | — | — | 7,556 | — | ||||||||||||||||
Mark to market (gains) losses | (9,911) | — | — | — | — | (10,139) | — | ||||||||||||||||
Gain on asset sales | — | — | — | — | — | (125) | — | ||||||||||||||||
Gain on disposal of businesses | — | — | — | — | — | (76,417) | — | ||||||||||||||||
Insurance proceeds, net of asset write-downs | — | — | — | — | — | (2,878) | — | ||||||||||||||||
Impairment of property, plant and equipment and lease assets | — | — | — | — | — | 740 | — | ||||||||||||||||
Impairment of goodwill | — | — | — | — | — | 36,684 | — | ||||||||||||||||
Restructuring and costs for legal matters | — | — | — | — | — | 459 | — | ||||||||||||||||
Other items | (80) | — | — | — | — | (7) | — | ||||||||||||||||
Adjustments from equity method investments | — | — | — | — | 9,708 | 9,708 | — | ||||||||||||||||
Income tax on items above and discrete tax items | — | — | — | 13,560 | (398) | 13,162 | — | ||||||||||||||||
NCI impact on items above | — | — | — | — | — | — | — | ||||||||||||||||
Adjusted (Non-GAAP) | $ | 10,604 | 10,745 | (72,264) | (62,089) | 17,618 | 151,042 | $ | — | ||||||||||||||
Year Ended December 31, 2025 (U.S. Dollars and shares in thousands, except per share amounts) | ||||||||||||||
Net income (loss) | Net income attributable to noncontrolling interests | Net (loss) income attributable to Dole plc | Diluted net income per share | |||||||||||
Reported (GAAP) | $ | 81,975 | (30,656) | $ | 51,319 | $ | 0.54 | |||||||
Loss from discontinued operations, net of income taxes | 45,959 | — | 45,959 | |||||||||||
Amortization of intangible assets | 7,102 | — | 7,102 | |||||||||||
Mark to market (gains) losses | 18,753 | — | 18,753 | |||||||||||
Gain on asset sales | (12,254) | — | (12,254) | |||||||||||
Gain on disposal of businesses | (606) | — | (606) | |||||||||||
Insurance proceeds, net of asset write-downs | (16,812) | — | (16,812) | |||||||||||
Impairment of property, plant and equipment and lease assets | 10,611 | — | 10,611 | |||||||||||
Restructuring and costs for legal matters | 3,786 | — | 3,786 | |||||||||||
Debt refinancing expenses | 3,182 | — | 3,182 | |||||||||||
Other items | 2,593 | — | 2,593 | |||||||||||
Adjustments from equity method investments | (10,115) | — | (10,115) | |||||||||||
Income tax on items above and discrete tax items | 12,846 | — | 12,846 | |||||||||||
NCI impact on items above | — | (1,324) | (1,324) | |||||||||||
Adjusted (Non-GAAP) | $ | 147,020 | (31,980) | $ | 115,040 | $ | 1.20 | |||||||
Weighted average shares outstanding – diluted | 95,902 | |||||||||||||
Year Ended December 31, 2024 (U.S. Dollars and shares in thousands, except per share amounts) | ||||||||||||||
Net income (loss) | Net income attributable to noncontrolling interests | Net (loss) income attributable to Dole plc | Diluted net income per share | |||||||||||
Reported (GAAP) | $ | 143,419 | (17,906) | $ | 125,513 | $ | 1.31 | |||||||
Loss from discontinued operations, net of income taxes | 28,880 | — | 28,880 | |||||||||||
Amortization of intangible assets | 7,556 | — | 7,556 | |||||||||||
Mark to market (gains) losses | (10,139) | — | (10,139) | |||||||||||
Gain on asset sales | (125) | — | (125) | |||||||||||
Gain on disposal of business | (76,417) | — | (76,417) | |||||||||||
Insurance proceeds, net of asset write-downs | (2,878) | — | (2,878) | |||||||||||
Impairment of property, plant and equipment and lease assets | 740 | — | 740 | |||||||||||
Impairment of goodwill | 36,684 | — | 36,684 | |||||||||||
Restructuring and costs for legal matters | 459 | — | 459 | |||||||||||
Other items | (7) | — | (7) | |||||||||||
Adjustments from equity method investments | 9,708 | — | 9,708 | |||||||||||
Income tax on items above and discrete tax items | 13,162 | — | 13,162 | |||||||||||
NCI impact on items above | — | (12,239) | (12,239) | |||||||||||
Adjusted (Non-GAAP) | $ | 151,042 | (30,145) | $ | 120,897 | $ | 1.27 | |||||||
Weighted average shares outstanding – diluted | 95,471 | |||||||||||||
Revenue for the Three Months Ended | |||||||||||||||||||||||||||||
December 31, 2024 | Impact of Foreign Currency Translation | Impact of Acquisitions and Divestitures | Like-for-like Increase (Decrease) | December 31, 2025 | |||||||||||||||||||||||||
(U.S. Dollars in thousands) | |||||||||||||||||||||||||||||
Fresh Fruit | $ | 819,066 | $ | 217 | $ | — | $ | 54,753 | $ | 874,036 | |||||||||||||||||||
Diversified Fresh Produce - EMEA | 910,604 | 76,978 | (3,015) | 41,320 | 1,025,887 | ||||||||||||||||||||||||
Diversified Fresh Produce - Americas & ROW | 463,285 | (58) | — | 23,228 | 486,455 | ||||||||||||||||||||||||
Intersegment | (25,491) | — | — | 5,275 | (20,216) | ||||||||||||||||||||||||
Total | $ | 2,167,464 | $ | 77,137 | $ | (3,015) | $ | 124,576 | $ | 2,366,162 | |||||||||||||||||||
Adjusted EBITDA for the Three Months Ended | |||||||||||||||||||||||||||||
December 31, 2024 | Impact of Foreign Currency Translation | Impact of Acquisitions and Divestitures | Like-for-like Increase (Decrease) | December 31, 2025 | |||||||||||||||||||||||||
(U.S. Dollars in thousands) | |||||||||||||||||||||||||||||
Fresh Fruit | $ | 31,890 | $ | (382) | $ | 178 | $ | (5,084) | $ | 26,602 | |||||||||||||||||||
Diversified Fresh Produce - EMEA | 32,487 | 3,723 | (96) | (3,517) | 32,597 | ||||||||||||||||||||||||
Diversified Fresh Produce - Americas & ROW | 10,234 | (99) | (750) | 4,083 | 13,468 | ||||||||||||||||||||||||
Total | $ | 74,611 | $ | 3,242 | $ | (668) | $ | (4,518) | $ | 72,667 | |||||||||||||||||||
Revenue for the Year Ended | |||||||||||||||||||||||||||||
December 31, 2024 | Impact of Foreign Currency Translation | Impact of Acquisitions and Divestitures | Like-for-like Increase (Decrease) | December 31, 2025 | |||||||||||||||||||||||||
(U.S. Dollars in thousands) | |||||||||||||||||||||||||||||
Fresh Fruit | $ | 3,293,527 | $ | 754 | $ | — | $ | 320,846 | $ | 3,615,127 | |||||||||||||||||||
Diversified Fresh Produce - EMEA | 3,608,692 | 171,992 | (31,678) | 267,567 | 4,016,573 | ||||||||||||||||||||||||
Diversified Fresh Produce - Americas & ROW | 1,686,281 | (3,388) | (79,307) | 52,621 | 1,656,207 | ||||||||||||||||||||||||
Intersegment | (113,157) | — | — | (1,843) | (115,000) | ||||||||||||||||||||||||
Total | $ | 8,475,343 | $ | 169,358 | $ | (110,985) | $ | 639,191 | $ | 9,172,907 | |||||||||||||||||||
Adjusted EBITDA for the Year Ended | |||||||||||||||||||||||||||||
December 31, 2024 | Impact of Foreign Currency Translation | Impact of Acquisitions and Divestitures | Like-for-like Increase (Decrease) | December 31, 2025 | |||||||||||||||||||||||||
(U.S. Dollars in thousands) | |||||||||||||||||||||||||||||
Fresh Fruit | $ | 214,848 | $ | (744) | $ | 565 | $ | (24,827) | $ | 189,842 | |||||||||||||||||||
Diversified Fresh Produce - EMEA | 131,504 | 8,349 | 42 | 10,086 | 149,981 | ||||||||||||||||||||||||
Diversified Fresh Produce - Americas & ROW | 45,851 | (451) | (2,724) | 12,877 | 55,553 | ||||||||||||||||||||||||
Total | $ | 392,203 | $ | 7,154 | $ | (2,117) | $ | (1,864) | $ | 395,376 | |||||||||||||||||||
December 31, 2025 | December 31, 2024 | |||||||||||||
(U.S. Dollars in thousands) | ||||||||||||||
Cash and cash equivalents (Reported GAAP) | $ | 267,854 | $ | 330,017 | ||||||||||
Debt (Reported GAAP): | ||||||||||||||
Long-term debt, net | (799,814) | (866,075) | ||||||||||||
Current maturities | (57,668) | (80,097) | ||||||||||||
Bank overdrafts | (9,611) | (11,443) | ||||||||||||
Total debt, net | (867,093) | (957,615) | ||||||||||||
Less: Debt discounts and debt issuance costs (Reported GAAP) | (7,237) | (9,531) | ||||||||||||
Total gross debt | (874,330) | (967,146) | ||||||||||||
Net Debt (Non-GAAP) | $ | (606,476) | $ | (637,129) | ||||||||||
LTM Adjusted EBITDA (Non-GAAP) | 395,376 | 392,203 | ||||||||||||
Net Leverage (Non-GAAP) | 1.5x | 1.6x | ||||||||||||
Last Twelve Months ("LTM") Adjusted EBITDA | ||||||||||||||
FY'25 Adjusted EBITDA | 395,376 | 392,203 | ||||||||||||
LTM Adjusted EBITDA | $ | 395,376 | $ | 392,203 | ||||||||||
Year Ended | |||||||||||
December 31, 2025 | December 31, 2024 | ||||||||||
(U.S. Dollars in thousands) | |||||||||||
Net cash provided by operating activities - continuing operations (Reported GAAP) | $ | 123,206 | $ | 262,721 | |||||||
Less: Capital expenditures (Reported GAAP)9 | (121,497) | (82,435) | |||||||||
Free cash flow from continuing operations (Non-GAAP) | $ | 1,709 | $ | 180,286 | |||||||